tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Balance Sheet

Compare
399 Followers

Kymera Therapeutics Balance Sheet

Kymera Therapeutics's total assets for Q3 2025 were $1.10B, a decrease of -2.57% from the previous quarter. KYMR total liabilities were $155.79M for the fiscal quarter, a -2.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 978.03M$ 575.76M$ 603.13M$ 605.90M$ 487.18M
Total Liabilities
$ 142.42M$ 180.79M$ 112.98M$ 146.27M$ 203.29M
Total Equity Gross Minority
$ 835.62M$ 394.97M$ 490.15M$ 459.64M$ 283.89M
Other Metrics
Currency in USD

Kymera Therapeutics Debt to Assets